Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marsh & Mclennan Companies (MRSH) EBT (2016 - 2025)

Historic EBT for Marsh & Mclennan Companies (MRSH) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • Marsh & Mclennan Companies' EBT rose 465.81% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.5 billion, marking a year-over-year increase of 107.66%. This contributed to the annual value of $5.5 billion for FY2025, which is 107.66% up from last year.
  • Marsh & Mclennan Companies' EBT amounted to $1.1 billion in Q4 2025, which was up 465.81% from $1.0 billion recorded in Q3 2025.
  • In the past 5 years, Marsh & Mclennan Companies' EBT registered a high of $1.9 billion during Q1 2024, and its lowest value of $613.0 million during Q4 2022.
  • For the 5-year period, Marsh & Mclennan Companies' EBT averaged around $1.2 billion, with its median value being $1.1 billion (2021).
  • In the last 5 years, Marsh & Mclennan Companies' EBT soared by 7796.3% in 2021 and then tumbled by 3621.23% in 2022.
  • Quarter analysis of 5 years shows Marsh & Mclennan Companies' EBT stood at $961.0 million in 2021, then tumbled by 36.21% to $613.0 million in 2022, then surged by 70.96% to $1.0 billion in 2023, then dropped by 3.72% to $1.0 billion in 2024, then increased by 4.66% to $1.1 billion in 2025.
  • Its EBT stands at $1.1 billion for Q4 2025, versus $1.0 billion for Q3 2025 and $1.6 billion for Q2 2025.